The World Health Organization director-general has criticized the Trans-Pacific Partnership for its impact on drug costs.
Margaret Chan said she has "some very serious concerns" about the TPP and that, "If these agreements open trade yet close the door to affordable medicines we have to ask the question: is this really progress at all." She added, "Can you bear the cost of $1,000 for a pill to treat Hepatitis C? Unless we get these prices down many millions of people will be left behind."
Transnational pharmaceutical corporations are highly profitable businesses that are seeking to increase those profits through extended patent protection provisions in so-called "free trade" agreements like the Trans-Pacific Partnership and the Canada-European Union Comprehensive Economic and Trade Agreement (CETA).